Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Dose-dependent effects of platelet-derived growth factor-B on glial tumorigenesis.

Shih AH, Dai C, Hu X, Rosenblum MK, Koutcher JA, Holland EC.

Cancer Res. 2004 Jul 15;64(14):4783-9.

2.

Platelet-derived growth factor in human glioma.

Westermark B, Heldin CH, Nistér M.

Glia. 1995 Nov;15(3):257-63. Review.

PMID:
8586462
3.

Platelet-derived growth factor (PDGF) and glial tumorigenesis.

Shih AH, Holland EC.

Cancer Lett. 2006 Feb 8;232(2):139-47. Epub 2005 Aug 31. Review.

PMID:
16139423
4.

Platelet-derived growth factor-mediated gliomagenesis and brain tumor recruitment.

Fomchenko EI, Holland EC.

Neurosurg Clin N Am. 2007 Jan;18(1):39-58, viii. Review.

PMID:
17244553
5.

Recent insights into PDGF-induced gliomagenesis.

Calzolari F, Malatesta P.

Brain Pathol. 2010 May;20(3):527-38. doi: 10.1111/j.1750-3639.2009.00335.x. Epub 2009 Sep 25. Review.

PMID:
19832839
6.

Angiogenesis-related growth factors in brain tumors.

Lamszus K, Heese O, Westphal M.

Cancer Treat Res. 2004;117:169-90. Review.

PMID:
15015561
7.

Identifying candidate genes involved in brain tumor formation.

Johansson Swartling F.

Ups J Med Sci. 2008;113(1):1-38. Review.

PMID:
18521796
8.

Antiangiogenic therapy in malignant glioma: promise and challenge.

Sathornsumetee S, Rich JN.

Curr Pharm Des. 2007;13(35):3545-58. Review.

PMID:
18220791
9.
10.

PDGF receptors-mediators of autocrine tumor growth and regulators of tumor vasculature and stroma.

Ostman A.

Cytokine Growth Factor Rev. 2004 Aug;15(4):275-86. Review.

PMID:
15207817
11.

PDGF and PDGF receptors in glioma.

Nazarenko I, Hede SM, He X, Hedrén A, Thompson J, Lindström MS, Nistér M.

Ups J Med Sci. 2012 May;117(2):99-112. doi: 10.3109/03009734.2012.665097. Epub 2012 Apr 17. Review.

12.

Roles of platelet-derived growth factor in the developing and mature nervous systems.

Valenzuela CF, Kazlauskas A, Weiner JL.

Brain Res Brain Res Rev. 1997 Jun;24(1):77-89. Review.

PMID:
9233543
13.

Clinical trials of small molecule inhibitors in high-grade glioma.

Day SE, Waziri A.

Neurosurg Clin N Am. 2012 Jul;23(3):407-16. doi: 10.1016/j.nec.2012.04.004. Epub 2012 Jun 8. Review.

PMID:
22748653
14.

Role of platelet-derived growth factor in mesangium development and vasculopathies: lessons from platelet-derived growth factor and platelet-derived growth factor receptor mutations in mice.

Betsholtz C, Lindblom P, Bjarnegard M, Enge M, Gerhardt H, Lindahl P.

Curr Opin Nephrol Hypertens. 2004 Jan;13(1):45-52. Review.

PMID:
15090859
15.

[Molecular aberration in brain tumor].

Shirahata M, Takahashi JA.

Nihon Rinsho. 2005 Sep;63 Suppl 9:24-9. Review. Japanese. No abstract available.

PMID:
16201495
16.

Growth factors in glioma angiogenesis: FGFs, PDGF, EGF, and TGFs.

Dunn IF, Heese O, Black PM.

J Neurooncol. 2000 Oct-Nov;50(1-2):121-37. Review.

PMID:
11245272
17.

Platelet-derived growth factor: a general review with emphasis on astrocytomas.

Guha A.

Pediatr Neurosurg. 1991-1992;17(1):14-20. Review.

PMID:
1667361
18.

Platelet-derived growth factor in glioblastoma-driver or biomarker?

Westermark B.

Ups J Med Sci. 2014 Nov;119(4):298-305. doi: 10.3109/03009734.2014.970304. Epub 2014 Oct 24. Review.

19.

Structural and functional studies on platelet-derived growth factor.

Heldin CH.

EMBO J. 1992 Dec;11(12):4251-9. Review. No abstract available.

20.

The role of transforming growth factor beta in glioma progression.

Jennings MT, Pietenpol JA.

J Neurooncol. 1998 Jan;36(2):123-40. Review.

PMID:
9525812

Supplemental Content

Support Center